Phase Ib/II trial of tisotumab vedotin (TV) +/- bevacizumab (BEV), pembrolizumab (PEM), or carboplatin (CBP) in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024) Meeting Abstract
| Authors: | Vergote, I.; Concin, N.; Mirza, M. R.; Andreassen, C. M.; Lorusso, D.; Gennigens, C. N.; Banerjee, S. N.; O'Cearbhaill, R. E.; Campos, S.; Nicacio, L. V.; Eaton, L.; O'Malley, D. M.; Soumaoro, I.; Monk, B. J. |
| Abstract Title: | Phase Ib/II trial of tisotumab vedotin (TV) +/- bevacizumab (BEV), pembrolizumab (PEM), or carboplatin (CBP) in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309187 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS6095 |
| Notes: | Meeting Abstract: TPS6095 -- Source: Wos |
